Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group
T Delozier, M Spielmann, J Macé-Lesec'h, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
March 23, 2007
[Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?]
G André, C Tunon-de-Lara, G Macgrogan, et al.
American Journal of Clinical Oncology
|
January 22, 2002
Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment--the experience of one institute
C Tunon-de-Lara, I de-Mascarel, G Mac-Grogan, et al.
International Journal of Cancer
|
May 14, 1998
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)
H Mignotte, C Lasset, V Bonadona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2007
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
L Mauriac, A Keshaviah, M Debled, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2011
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
G Viale, M M Regan, P Dell'Orto, et al.
Gynecologie, Obstetrique & Fertilite
|
July 9, 2003
[Standards, options and recommendations for the management of patients with infiltrating non metastatic breast cancer (2nd edition, 2001)--summary version]
L Mauriac, E Luporsi, B Cutuli, et al.
Bulletin Du Cancer
|
October 2, 2001
[Standards, options and recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients]
J M Coindre, M P Blanc-Vincent, F Collin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 13, 2002
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]
A Fourquet, B Cutuli, E Luporsi, et al.
British Journal of Cancer
|
August 14, 2003
Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001)
L Mauriac, E Luporsi, B Cutuli, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2000
Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group
T Delozier, M Spielmann, J Macé-Lesec'h, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|
March 23, 2007
[Bilateral ductal carcinoma in situ of the breast: independent events or bilateral disease?]
G André, C Tunon-de-Lara, G Macgrogan, et al.
American Journal of Clinical Oncology
|
January 22, 2002
Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment--the experience of one institute
C Tunon-de-Lara, I de-Mascarel, G Mac-Grogan, et al.
International Journal of Cancer
|
May 14, 1998
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC)
H Mignotte, C Lasset, V Bonadona, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 16, 2007
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
L Mauriac, A Keshaviah, M Debled, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 22, 2011
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
G Viale, M M Regan, P Dell'Orto, et al.
Gynecologie, Obstetrique & Fertilite
|
July 9, 2003
[Standards, options and recommendations for the management of patients with infiltrating non metastatic breast cancer (2nd edition, 2001)--summary version]
L Mauriac, E Luporsi, B Cutuli, et al.
Bulletin Du Cancer
|
October 2, 2001
[Standards, options and recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients]
J M Coindre, M P Blanc-Vincent, F Collin, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
September 13, 2002
["Standards, Options and Recommendations 2001" for radiotherapy in patients with non-metastatic infiltrating breast cancer. Update. National Federation of Cancer Campaign Centers (FNCLCC)]
A Fourquet, B Cutuli, E Luporsi, et al.
British Journal of Cancer
|
August 14, 2003
Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001)
L Mauriac, E Luporsi, B Cutuli, et al.
Page
of 9